He Jiankui, the Chinese researcher who stunned the scientific world with his claim of having genetically altered a set of twins born this month, defended ...

Tel Aviv, Israel, November 26, 2018…CannaLean, an Israeli company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) an...

Canton, Massachusetts (November 29, 2018) - In today’s diagnostic environment, innovations continue at a rapid pace, with emerging molecular diagnostic manufacturers ...

In the framework of a preferred partnership, Yposkesi plans to grant Axovant access to dedicated cGMP capacity and manufacturing resources to further support the glob...

Keele, UK, Port Washington, USA, and London, UK, 26 November 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO...

Less than a week ago, Roche snagged regulatory approval for Xofluza, a single-dose oral medication, the first new flu treatment approved in 20 years. Now, new resea...

Roivant says it will form a new company to take the program forward. (CDC/Matthew Arduino/Janice Haney Carr)...

In animal models, Genentech's inhaled JAK1 inhibitor seemed to act solely in the lungs, which could be a safety advant...

The gut microbiome is widely viewed as potential target for novel therapeutics, and not just for its role in gastrointestinal conditions such as inflammatory bowel di...

Krakow, Poland, November 21, 2018 / B3C newswire / -- Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the research and developme...